1. Challenges in the management of sickle cell disease during pregnancy in Senegal, West Africa
- Author
-
Moussa Seck, Blaise Felix Faye, Sokhna Aissatou Touré, Abibatou Sall, Nata Dieng, Macoura Gadji, Saliou Diop, Abdou Aziz Diouf, Kouassi Berenger Kouame, and Awa Oumar Touré
- Subjects
Adult ,medicine.medical_specialty ,Anemia, Sickle Cell ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Internal medicine ,medicine ,Humans ,Prospective Studies ,030212 general & internal medicine ,Fetal loss ,Prospective cohort study ,Fetus ,030219 obstetrics & reproductive medicine ,Hematology ,business.industry ,Obstetrics ,Gestational age ,medicine.disease ,Africa, Western ,Female ,business ,Live birth - Abstract
The aim of this study was to evaluate the maternal and fetal complications in pregnant patients with sickle cell disease (SCD) and find risk factors of stillbirth.We conducted a prospective study in pregnant women with SCD. Demographic characteristics, maternal and fetal morbi-mortality, and outcome of pregnancies were described. Risk factors of fetal loss were evaluated by comparing the parameters of the pregnancies that led to a live birth with those interrupted.We included 70 pregnancies in 58 women with SCD. The average age was 29.3 years. The average gestational age at the start of follow-up was 13 weeks. The occurrence of acute complications was significantly higher during pregnancy compared to the year before (p 0.05). Maternal mortality was 0%. Live birth rate was 80%. Fetal loss rate was 3.9 times higher in previous pregnancies that had not been monitored in hematology (71.8 versus 18.6%). Stillbirth was associated with nulliparity, high leukocytes or platelet counts (p 0.05).Pregnancy in SCD was associated with a high maternal morbidity and stillbirth. Nulliparity, high leucokocytes or platelet count were identified as risk factors of fetal loss.
- Published
- 2017
- Full Text
- View/download PDF